Skip to content

Homoeopathic Treatment for joint pains

Assessment of Likelihood Ratio for four symptoms of Homoeopathic medicine Colchicum autumnale related to patients of Gout.

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
CTRI
Registry ID
CTRI/2022/04/041572
Enrollment
100
Registered
2022-04-01
Start date
Unknown
Completion date
Unknown
Last updated
2022-10-17

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: M109- Gout, unspecified

Interventions

None listed

Sponsors

National Institute of Homoeopathy
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: a) Patients suffering from Gout diagnosed as per ACR-EULAR Gout classification criteria. b) Patients of age group 18-65 years and of both sexes. c) Patients having ability to read English, Bengali, Hindi. d) Patients who provided written consent to participate in the study.

Exclusion criteria

Exclusion criteria: a) Unwilling to participate or to comply with the study requirements. b) Too unwell to take part in the study. c) Having other uncontrolled psychiatric illness or systemic diseases and/or pathologies affecting quality of life. d) Those who are using homoeopathic medicines for any chronic disease. e) Having self-reported immune-compromised state. f) Having drug or substance abuse and/or dependence. g) Pregnant women or lactating mothers.

Design outcomes

Secondary

MeasureTime frame
I. To estimate the changes in serum uric acid level (baseline vs. 6 months). II. To estimate the changes in Gout Assessment Questionnaire (GAQ2) over 3 months and 6 months of treatment. III. To estimate the changes in Measure Yourself Medical Outcome Profile (MYMOP2) at baseline, every month up to 6 months. IV. To study the correlations between Outcome in Relation to Impact on Daily Living (ORIDL) previously known as Glasgow Homoeopathic Hospital Outcome Scale (GHHOS) and changes in GAQ2 at baseline, 3 months & 6 months. V. To assess the responsiveness of GAQ scales: mean GAQ change scores by serum uric acid level at follow up of 3 months and 6 months.Timepoint: All the enrolled participants will be allowed to receive 6 months of treatment. The outcomes will be measured at baseline, after 3 months, and after 6 months as per the applicability of assessment criteria. The result will be analysed after all the participants received the specified period of treatment of 6 months individually.

Primary

MeasureTime frame
To assess Likelihood Ratio of the following four symptoms of homoeopathic medicine Colchicum autumnale those are related to the patients of gout. I. Pins and needles sensation in hands and wrist. II. Tearing pain in limbs worse in evening and warm weather. III. Joints stiff and cannot bear to have it touched or moved. IV. Oedematous swelling of legs and feet. Timepoint: All the enrolled participants will be allowed to receive 6 months of treatment. The outcomes will be measured at baseline, after 3 months, and after 6 months as per the applicability of assessment criteria. The result will be analysed after all the participants received the specified period of treatment of 6 months individually.

Countries

India

Contacts

Public ContactDR SWAPAN PAUL

NATIONAL INSTITUTE OF HOMOEOPATHY

drspaul.2007@gmail.com9830148968

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026